GenMark Diagnostics to license RTP firm’s microfluidics technology
Microfluidics technology developed by Advanced Liquid Logic would become part of new diagnostics developed by GenMark Diagnostics (NASDAQ:GNMK) in a preliminary deal that would also give GenMark an equity stake in its new partner. GenMark has agreed to license “electrowetting” technology from Advanced Liquid Logic, or ALL, to develop in vitro diagnostics products. Under the […]